{"name":"BioTissue Holdings, Inc","slug":"biotissue-holdings-inc","ticker":"","exchange":"","domain":"","description":"BioTissue Holdings, Inc is a biotechnology company focused on the development of innovative treatments for various medical conditions. The company has a portfolio of seven drugs, with one currently marketed and others in different stages of development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Saline (NaCl 0,9 %) (placebo)","genericName":"Saline (NaCl 0,9 %) (placebo)","slug":"saline-nacl-0-9-placebo","indication":"Placebo control in clinical trials","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TTAX01","genericName":"TTAX01","slug":"ttax01","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Saline (NaCl 0,9 %) (placebo)","genericName":"Saline (NaCl 0,9 %) (placebo)","slug":"saline-nacl-0-9-placebo","phase":"marketed","mechanism":"Normal saline (0.9% NaCl) is an isotonic solution that maintains fluid and electrolyte balance without pharmacological activity, serving as a physiological control or placebo.","indications":["Placebo control in clinical trials","Fluid and electrolyte replacement (clinical use)"],"catalyst":""},{"name":"TTAX01","genericName":"TTAX01","slug":"ttax01","phase":"phase_3","mechanism":"TTAX01 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-26","type":"pipeline","source":"simplywall.st","summary":"BioStem Governance And Hospital Expansion Moves Shape Investor Focus - simplywall.st","headline":"BioStem Governance And Hospital Expansion Moves Shape Investor Focus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxNcVoxazZVeTFxMkVSbERDcC1IR0M2dFVLaS1xR05ETE1Td3pVYzRKM3ozMTNMeFh1UVhtSFJEMHZ6YUVsdU43VWZGRWt3WDY0RzdCbTQ5WWtZSENieWVSZFBwWnE5RnlONm1yTXJVVXIwSXB6SDZEdF93d0cwNDJfMThXaFkyR01KOVVDLWp3dF83NXdpa3d5X0JDQlpYRnRJRWp3aE4wWHB2UmdGSG56ZzFkSDhWcnlkeXpEMUptU2cyRGxkYV9fbmlHUE9WVmNWZUVHM1oxeU1XYkZhS3pOdW5ZRW9COGRxUDNWMlpFR3g5bnJydHhuSjJwdF9nb3JoaHprenVkQmtLY2U1U3lLa3dKbU82alBBZGRqZTZvTjYwMkU?oc=5","date":"2026-01-21","type":"pipeline","source":"PR Newswire","summary":"BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business to BioStem Technologies - PR Newswire","headline":"BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business t","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxPdllGTWJIUUtYb093ZTNlN01pR09HSDZzZUtnZDRhdVY5ZHBTMTRWSGRhZFFlR1RkLU9hUVc4SzI3eTI5NjUtdlhjamNxX0p3TWIzLXZ1UFJ2aWE0MjN6MjRXTzZsbGNZZ0dib0l5OUpXTUpVNjRZUVNYbU1VRkZnZDRGSFVFdjhhb05qczFGZTBTbnltN29OaUZDbk5NOF9qVHVHT3RSUkxseGN4RWZ2d2dLcW9Hdm5vVFJQZ1FhVkc1MGFneHZQdnhSQTdRQlJVWlpKalkxZ2d3TTY1a0lQaUpqbWZjN0NjSFRJNG51UU10TkFWMUl4Y0tlTGpFRm41Zk5Oel9DcDdGdEpfWjRZZmRjcTk0Sy1VVGE0RDJlMEsxQnlVYTdvNVIzSkNEd2dGQ0QxNUNOVQ?oc=5","date":"2026-01-21","type":"pipeline","source":"GlobeNewswire","summary":"BioStem Technologies Advances Entry into the Acute Wound - GlobeNewswire","headline":"BioStem Technologies Advances Entry into the Acute Wound","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPV29IbWJZa25IZkZhUS1LLWFadnA1dmV0WUI3eDVBT3I2SEk0ZU9JdVVza1NoUzVDSVBZVmhjTUtEYjJwdkZpUXhHdGtLdncxSzhtWG1xM1dDT0RiR2pXREtqUms5LTJpeTdaYlBTOGVHem9yWkh3d2RfRDhDbzRRVm5VaGxTdDFCZzJ4N3pqTkdOYjA?oc=5","date":"2024-06-24","type":"regulatory","source":"Yahoo Finance","summary":"Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion - Yahoo Finance","headline":"Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBBTFVsZ1VUaE96T2JValJOUzlZMm1XUTdUbEJvRDNEdW5WNjVvNktETWpRdV9vR3BIUUN6ZWdOQjFvOE8zT2o3NHZPclhTZnliYVE?oc=5","date":"2017-05-28","type":"pipeline","source":"au.finance.yahoo.com","summary":"BioStem Technologies, Inc. (BSEM) stock price, news, quote and history - au.finance.yahoo.com","headline":"BioStem Technologies, Inc. (BSEM) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}